NASDAQ:RDCM

RADCOM Ltd. (NASDAQ:RDCM) Q2 2026 Earnings: Navigating Delays with Strong Financials

Font: Financial Modeling Prep  • Aug 12, 2026

Market Chart
  • RADCOM Ltd. (NASDAQ:RDCM) reported a Q2 2026 EPS of -$0.09, missing the $0.24 estimate, with revenue at $11.76 million, a 33.4% decrease, primarily due to deployment delays.
  • Despite the quarterly miss, RADCOM secured three new contracts and announced a $20 million to $25 million share repurchase program, signaling management's confidence.
  • The company maintains robust financial health, evidenced by a strong current ratio of 6.32 and a low debt-to-equity ratio of 0.025.

RADCOM Ltd. (NASDAQ:RDCM) is a company that provides specialized software for telecom network assurance. It holds a strong market position and, as highlighted by Seeking Alpha, reports no customer cancellations or competitive losses. This software helps telecom operators monitor and manage the quality of their networks.

On August 12, 2026, RADCOM's earnings report shows an earnings per share (EPS) of -$0.09. This result misses the consensus analyst estimate, which was set at $0.24 per share. Despite this quarterly figure, the company maintains profitability on a non-GAAP basis for the first six months of 2026.

The company's revenue for the quarter is $11.76 million, falling short of the $15.57 million estimate. This figure represents a 33.4% decrease from the second quarter of 2025. As announced by PR Newswire, RADCOM attributes this decline to deployment delays at some customers, which are caused by higher component costs.

Management believes these delays are related to timing rather than a fundamental change in demand for its products. Following the quarter's end, RADCOM secures three new contracts. The company’s board is also moving to establish a share repurchase program valued between $20 million and $25 million.

Looking at its financial health, RADCOM has a current ratio of 6.32. A current ratio measures a company's ability to pay its short-term obligations, with a number above 1 generally seen as healthy. The company also has a low debt-to-equity ratio of 0.025, indicating it relies very little on debt.

Market Overview
LIMN
Liminatus Pharma, Inc. Class A Common Stock
$0.16
44.79%
IVDA
Iveda Solutions, Inc.
$0.50
35.05%
OPEN
Opendoor Technologies Inc.
$3.61
3.30%
ONDS
Ondas Holdings Inc.
$8.88
-9.11%
DFSC
DEFSEC Technologies Inc.
$2.50
101.94%
SMCI
Super Micro Computer, Inc.
$39.48
4.97%
FGI
FGI Industries Ltd.
$13.48
184.99%
NOK
Nokia Oyj
$10.61
2.81%
TSLL
Direxion Daily TSLA Bull 2X ETF
$8.58
6.52%
RCON
Recon Technology, Ltd.
$0.03
5.00%